Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.

Cochrane database of systematic reviews (Online)

Volumn 2, Issue , 2010, Pages

  Robinson, Karen A ^a   Odelola, Olaide A ^a   Saldanha, Ian ^a   McKoy, Naomi ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; PALIVIZUMAB;

CYSTIC FIBROSIS; HUMAN; INFANT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CYSTIC FIBROSIS; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; ANTIBODIES, MONOCLONAL, HUMANIZED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84861325376     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (48)